However, the patient continued to present episodes of severe febrile neutropenia with concomitant AKI; therefore, monthly administration of G-CSF was switched to alternate day (2 mcg/kg/24 h) with favorable outcome. The gene discussed is CSF3; the disease is acute kidney injury.